FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1738611000001104: Valni 20 Retard tablets (Neolab Limited) 56 tablet (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25206301000001110 Valni 20 Retard tablets (Neolab Limited) 56 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
56371401000001118 Valni 20 Retard tablets (Tillomed Laboratories Ltd) 56 tablet en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Is a Nifedipine 20mg modified-release tablets 56 tablet true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Is pack of Valni 20 Retard tablets (Neolab Limited) false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has active ingredient Nifedipine false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has excipient Lactose false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Discontinued indicator Discontinued AMPP(qualifier value) false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet VMP prescribing status (attribute) Not recommended to prescribe as a VMP false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has AMP Valni 20 Retard tablets (Neolab Limited) true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has specific active ingredient Nifedipine true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Has dispensed dose form Modified-release oral tablet true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet VMP prescribing status (attribute) VMP not recommended to prescribe - brands not bioequivalent false Inferred relationship Existential restriction modifier
Valni 20 Retard tablets (Neolab Limited) 56 tablet Discontinued indicator Re-marketed true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start